Evidence map›Paper›PMID 31772944›Full record

ArticleJournal of diabetes research2019

The Gut Microbiota in Women Suffering from Gestational Diabetes Mellitus with the Failure of Glycemic Control by Lifestyle Modification.

Guangyong Ye, Long Zhang, Min Wang, Yunbo Chen, Silan Gu, Keyi Wang, Jianhang Leng, Yujia Gu, Xinyou Xie

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 6 pooled it
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 6 syntheses or guidelines pooled it, 98 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. A Review of Modulation of Gut Microbiota to Mitigate Gestational Diabetes: Implications for Maternal and Child Health.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  14. Article
  15. The advantages ofFuture microbiology · 2025
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Guangyong YeWomen's Hospital, Zhejiang University School of Medicine, China.ORCID https://orcid.org/0000-0001-5013-9797
Long ZhangWomen's Hospital, Zhejiang University School of Medicine, China.ORCID https://orcid.org/0000-0003-3298-0130
Min WangWomen's Hospital, Zhejiang University School of Medicine, China.
Yunbo ChenThe First Affiliated Hospital, Zhejiang University School of Medicine, China.
Silan GuThe First Affiliated Hospital, Zhejiang University School of Medicine, China.
Keyi WangCentral Laboratory, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, China.
Jianhang LengCentral Laboratory, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, China.
Yujia GuWomen's Hospital, Zhejiang University School of Medicine, China.
Xinyou XieDepartment of Clinical Laboratory, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, China.ORCID https://orcid.org/0000-0002-1215-7465
Women's Hospital, School of Medicine, Zhejiang University · CNFirst Affiliated Hospital Zhejiang University · CNHangzhou First People's Hospital · CNSir Run Run Shaw Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gestational diabetes mellitus (GDM) is prevalent worldwide, leading to a high risk of significant morbidity for both the mother and offspring with complications. Increasing evidences suggest that gut microbiota plays a role in the pathogenesis of GDM. Lifestyle modification is the cornerstones of GDM treatment. However, a number of patients whose blood glucose is not controlled by lifestyle modification still require exogenous insulin to control blood glucose. No observational study is available about the relationship between the gut microbiota in GDM patients and lifestyle modifications. Thus, we investigated the differences in gut microbiota between GDM patients with successful glycemic control (GDM1) and failure of glycemic control (GDM2) by lifestyle modifications. We sequenced the V3-V4 regions of 16S ribosomal ribonucleic acid (rRNA) gene from stool samples of 52 singleton pregnant women with 24-28 weeks of gestation. Our results showed that

Indexed as

Blood GlucoseGastrointestinal MicrobiomeLife StyleAdultDiabetes, GestationalFecesFemaleHumansInsulin ResistancePregnancyRNA, Ribosomal, 16SBlood GlucoseRNA, Ribosomal, 16S

Identifiers

PMID31772944
PMCPMC6854930
OpenAlexW2982124958

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.